4 minute read
Oct. 29, 2022

Vadadustat: an Oral Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Domain (HIF-PHD) Inhibitor

vadadustat

oral HIF-PHD enzyme inhibitor Ph. III candidate for anemia in CKD carboxylic acid class of HIF-PHD inhibitors J. Pharmacol. Exp. Ther., Oct 1, 2022 Akebia Therapeutics, Cambridge, MA

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in